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The Purdue Pharma Settlement: Should it have
been overturned?
On December 16, 2021, Judge Colleen McMahon of the U.S. District Court for the Southern District of New
York overturned the Purdue Pharma bankruptcy settlement.[1] Back in September of 2021, Judge Robert Drain of
the U.S. Bankruptcy Court approved a settlement plan devised by the Sackler family that aimed to put the
Oxycontin legal drama to rest. This settlement required the infamous Sackler Family to turn over 4.5 billion
dollars to settle upwards of 2,600 lawsuits[2] filed against them and their company, Purdue Pharma, surrounding
legal fallout stemming from their production of Oxycontin and alleged direct hand in the opioid epidemic.[3]
Although the amount Purdue was willing to give up in the first bankruptcy settlement seems like a hefty sum, this
settlement plan stipulated that the Sacklers would be permanently blocked from any future civil suits pertaining to
the opioid epidemic and their connection to it.[4] This small detail of the settlement caused an uproar from those
following Purdue’s handling of settlement. The stipulation seems incredibly unfair, considering the opioid
epidemic has taken at least 891,000 lives since 1999[5] and Oxycontin hit the market in 1996[6]. Judge McMahon
attributed her decision primarily to what bankruptcy code allows and does not allow. Specifically, she said, the
bankruptcy code does not give a judge the right to grant such releases.[7] However, she admits that while her
decision is clear, the language of the code is on uncertain ground, and calls the permissibility of such a grant, “the
great unsettled question.”[8]
With a base knowledge of the evils committed by the shameless Sacklers, Judge McMahon’s decision should
be applauded. However, further insight into the details of the overturned settlement, the future plans of the
“improved” settlement, and opinions from those most affected by Purdue Pharma, leave one to question whether
or not Judge McMahon should have overturned the settlement.
A common thread throughout the entire Sackler/Purdue settlement deal is the urge to get money into
communities and families harmed by Oxycontin as quickly as possible. Would the first settlement have achieved
this? Opinions are split. In exchange for shielding the Sacklers from any direct civil claims, the family planned to
pay 4.5 billion dollars.[9] This total would be paid in multiple sums over an approximately nine-year period.
Although the settlement stated that a majority of the pool would go to treatment centers and prevention programs
around the country,[10] compensation for individual claims would be miniscule.[11] Purdue had been using a
point system to determine the worth of a life, and thus payout from the settlement.[12] Lynn Wencus filed a claim
against Purdue Pharma after the 2017 death of her son to opioid addiction that began with Oxycontin.[13] Due to
the point system, even though Wencus paid over 100,000 dollars in medical bills for her son’s treatment, his death
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according to the point chart would only lead to a payment between 20,000-40,000 dollars.[14] The outcome of
the first settlement proved to be less than ideal for victim’s families, such as Lynn Wencus, so overturning the
decision would eradicate the Sackler protection clause and potentially give families like hers the opportunity to
sue directly to receive adequate damages. When the bankruptcy settlement was released with the protection
clause, many were angered by the decision. Maryland Attorney General Brian E. Frosh cheered Judge McMahon’s
decision as a restored opportunity to hold the Sackler family fully accountable.[15] William Tong, Attorney
General of Connecticut, similarly heralded the decision, calling it a “seismic victory for justice.”[16]
However, Judge McMahon’s decision worried advocates who have been eager to get funds meant to repair
the trail of hurt Oxycontin caused. Many families who dealt with the hurt from opioid-related deaths would rather
keep the first plan and accept that 90% of the 4.5 billion in funds would be dispersed to treatment centers and
intervention programs in order to mitigate any future harms and spare families from future hurt.[17] Ryan
Hampton, who was a victim chair on the Creditor Committee and had two of her sons die from opioid addiction,
supported the first settlement because of the proportion of funds going to treatment.[18] Purdue Chairman Steve
Miller even stated that Judge McMahon’s decision only acts to delay money that would be going to damaged
communities.[19] There is no right answer as to whether or not Judge McMahon should have overturned the first
settlement. The line between wanting accountability and wanting help is fine. Hopefully the next settlement will
bring both.
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